Editorial: rifaximin in cirrhosis-is this what we've been waiting for? Authors' reply

Aliment Pharmacol Ther. 2017 Nov;46(10):1017-1018. doi: 10.1111/apt.14343.

Authors

S H Kang^{1

2}, Y B Lee³, J-H Lee¹

Affiliations

¹ Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
² Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
³ Department of Internal Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea.

PMID: 29052857
DOI: 10.1111/apt.14343

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Liver Cirrhosis*
Rifamycins*
Rifaximin

Substances

Rifamycins
Rifaximin